You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Suppliers and packagers for generic pharmaceutical drug: DESIPRAMINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


DESIPRAMINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 074430 ANDA Actavis Pharma, Inc. 45963-341-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-341-02) 2006-05-09
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 074430 ANDA Actavis Pharma, Inc. 45963-346-50 50 TABLET, FILM COATED in 1 BOTTLE (45963-346-50) 2006-05-09
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071601 ANDA Actavis Pharma, Inc. 45963-342-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-342-02) 2006-05-01
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071588 ANDA Actavis Pharma, Inc. 45963-343-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-343-02) 2006-06-04
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071602 ANDA Actavis Pharma, Inc. 45963-344-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-344-02) 2006-05-08
Actavis Totowa DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 071766 ANDA Actavis Pharma, Inc. 45963-345-02 100 TABLET, FILM COATED in 1 BOTTLE (45963-345-02) 2006-07-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Desipramine Hydrochloride

Last updated: July 27, 2025

Introduction

Desipramine hydrochloride is a tricyclic antidepressant (TCA) primarily prescribed for major depressive disorder and certain phobias, characterized for its selective norepinephrine reuptake inhibition. Its secure and consistent supply chain is vital to ensure uninterrupted patient treatment. As an essential pharmaceutical ingredient, desipramine hydrochloride’s procurement involves multiple global suppliers, each with distinct manufacturing capacities, regulatory compliances, and quality standards. This report delineates the key suppliers for desipramine hydrochloride, their markets, and considerations for sourcing.

Global Manufacturing Landscape

Desipramine hydrochloride is produced predominantly by pharmaceutical ingredient (API) manufacturers across Asia, Europe, and North America. The complexity of synthesis, regulatory compliance, and quality assurance impact supplier selection. Global regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others enforce stringent manufacturing and documentation standards. Suppliers must adhere to Good Manufacturing Practices (GMP) to reliably deliver high-grade APIs.

Major Suppliers of Desipramine Hydrochloride


1. Hubei Hongjing Pharmaceutical Co., Ltd. (China)

Overview:
This Chinese manufacturer is among the leading providers of desipramine hydrochloride, supplying both bulk API and finished products. Hongjing emphasizes compliance with international GMP standards, with certifications aligning with USFDA and EMA requirements.

Capabilities & Market:

  • Extensive API production capacity with consistent quality control.
  • Offers various grades suitable for pharmaceutical formulation.
  • Competitive pricing driven by robust manufacturing infrastructure.

Regulatory & Quality:

  • Regular audits and certifications ensure compliance.
  • Provides batch documentation, stability data, and analytical reports for validation.

Distribution:

  • Supplies to global pharmaceutical companies, contract manufacturers, and generic drug producers.

2. Jiangxi Xuebao Pharmaceutical Co., Ltd. (China)

Overview:
Specialized in psychotropic APIs, Jiangxi Xuebao is known for competitively priced desipramine hydrochloride, with an expanding international footprint.

Capabilities & Market:

  • High-volume production aligned with international standards.
  • Known for rapid order fulfillment and consistent quality.

Regulatory & Quality:

  • GMP-certified manufacturing plant; audits conducted periodically.
  • Capable of providing comprehensive compliance documentation for regulatory submissions.

3. Searle Pharmaceuticals (India)

Overview:
A prominent Indian API manufacturer, Searle Pharmaceuticals supplies a range of psychotropic APIs, including desipramine hydrochloride. India is a key hub for generic pharmaceutical ingredients due to its cost advantages and industry standards.

Capabilities & Market:

  • Well-established supply chains targeting North America, Asia, and Europe.
  • Achieves high compliance standards for regulatory approval processes.

Regulatory & Quality:

  • Product meets USP, EP, and other pharmacopoeias.
  • Inspections routinely passed by major regulatory bodies.

4. ACTAVIS (Denmark/Global)

Overview:
As a global leader in generic pharmaceuticals, ACTAVIS offers high-quality desipramine hydrochloride as part of its API portfolio. The company emphasizes compliance, safety, and high-quality manufacturing.

Capabilities & Market:

  • Large-scale GMP manufacturing facilities.
  • Capable of supplying APIs for large-volume formulations.

Regulatory & Quality:

  • Holds comprehensive regulatory approvals across multiple regions.
  • Robust supply chain with strict quality assurance.

5. Teva Pharmaceutical Industries Ltd. (Israel)

Overview:
A global generic pharmaceutical giant, Teva offers a broad range of APIs, including desipramine hydrochloride. The company maintains high standards of GMP compliance and rigorous quality controls.

Capabilities & Market:

  • Extensive global distribution network.
  • Focused on delivering APIs that meet strict international standards.

Regulatory & Quality:

  • Regularly audited, with recognized certifications.
  • Committed to maintaining supply chain integrity.

Regional Focus and Regulatory Considerations

Sourcing from Chinese manufacturers offers cost advantages but mandates rigorous due diligence regarding GMP compliance, batch validation, and regulatory documentation. Indian suppliers are known for their robust regulatory adherence and are often preferred for North American and European markets. European and North American suppliers like ACTAVIS and Teva focus heavily on regulatory compliance, offering high-certainty supply chains but at higher costs.

Supply Chain Challenges and Risk Mitigation

To mitigate risks associated with geopolitical, regulatory, or supply disruptions, pharmaceutical companies should adopt diversified sourcing strategies. Engaging multiple suppliers across regions can help ensure supply continuity, compliance, and competitive pricing. It is also advisable to conduct comprehensive audits and ensure suppliers provide comprehensive documentation, including Certificates of Analysis (CoA), stability data, and GMP certifications.

Conclusion

The procurement of desipramine hydrochloride predominantly involves suppliers from China, India, and Europe, each offering varying benefits in cost, compliance, and capacity. Due diligence is vital to validate supplier credentials and ensure that the API meets quality standards mandated by regulatory frameworks such as the USP, EP, or other pharmacopeias.


Key Takeaways

  • Multiple regional suppliers exist for desipramine hydrochloride, with Chinese manufacturers offering cost-effective options and Indian/European suppliers emphasizing regulatory compliance.
  • Due diligence, including GMP certification verification and comprehensive documentation review, is critical when selecting suppliers.
  • Diversification of sourcing reduces supply risks amid geopolitical or regulatory uncertainties.
  • Maintaining strong supplier relationships and periodic auditing ensures consistent quality and compliance.
  • Pharmaceutical companies should tailor supplier choices based on targeted markets, cost considerations, and regulatory compliance requirements.

FAQs

1. What are the primary considerations when sourcing desipramine hydrochloride?
Regulatory compliance, GMP certification, consistent quality, supply capacity, and documentation integrity are critical. Companies should also evaluate supply chain robustness and geopolitical stability.

2. Are Chinese suppliers reliable for desipramine hydrochloride?
Many Chinese suppliers are reliable, with recognized GMP certifications. Due diligence, including audits and review of regulatory documentation, is essential.

3. How does regulatory compliance affect supplier selection?
Suppliers compliant with international standards such as GMP, USP, and EMA are preferred to ensure seamless regulatory approval and market access.

4. Is it advisable to use multiple suppliers for desipramine hydrochloride?
Yes, diversifying suppliers mitigates risks associated with supply disruption, quality issues, or geopolitical restrictions.

5. What documentation should be obtained from suppliers?
Certificates of Analysis (CoA), GMP certificates, batch release data, stability test results, and compliance certifications are necessary for validation and regulatory review.


Sources:

[1] US Food & Drug Administration – API Manufacturing Standards.
[2] European Medicines Agency – Good Manufacturing Practice Guidelines.
[3] Global Pharmaceutical API Market Reports, 2022.
[4] Company websites and supplier disclosures.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing